Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Naidi Wang"'
Publikováno v:
Chinese Medical Journal, Vol 137, Iss 10, Pp 1252-1254 (2024)
Externí odkaz:
https://doaj.org/article/2ff3739698914a86a1f4c9de9f64791b
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractIntroduction Low-dose interleukin-2 (IL-2) regulates the homeostasis of CD4+ T cells by modulating the proportions of effector and regulatory T cells, thus reducing disease activity in patients with systemic lupus erythematosus (SLE). However
Externí odkaz:
https://doaj.org/article/c42f56e07afc43a69aa2be464f88d390
Autor:
Xiaoyi Gao, Naidi Wang, Yuhong Chen, Xiaoxue Gu, Yuanhui Huang, Yang Liu, Fei Jiang, Jie Bai, Lu Qi, Shengpeng Xin, Yuxiang Shi, Chuanbin Wang, Yuliang Liu
Publikováno v:
PeerJ, Vol 9, p e12512 (2021)
H9N2 subtype avian influenza A virus (AIV) is a causative agent that poses serious threats to both the poultry industry and global public health. In this study, we performed active surveillance to identify H9N2 AIVs from poultry (chicken, duck, and g
Externí odkaz:
https://doaj.org/article/59c698f8653246a78081aa7587ee1abc
Publikováno v:
Journal of Industrial and Engineering Chemistry. 112:440-450
Autor:
Kai Zhang, Yuan An, Peng Zhao, Bo Huang, Yifan Wang, Xingyu Zhou, Gong Cheng, Xiaoyan Xing, Naidi Wang, Ruiling Feng, Siyue Yu, Min Li, Jing He, Zhanguo Li
Publikováno v:
Rheumatology (Oxford, England).
Objective To identify predictors for lupus low disease activity state (LLDAS), early-achieved LLDAS and long-term disease activity, and to refine a prognostic stratification tool for use in active SLE patients. Method A total of 245 active SLE patien
Autor:
Xingyu Zhou, Yifan Wang, Bo Huang, Ruiling Feng, Xinyao Zhou, Chun Li, Xia Zhang, Miao Shao, Yuzhou Gan, Yuebo Jin, Yuan An, Xian Xiao, Shiyang Wang, Qinghong Liu, Gong Cheng, Fengyunzhi Zhu, Kai Zhang, Naidi Wang, Xiaoyan Xing, Ru Li, Yuhui Li, Yisi Liu, Dan Lu, Xiaolin Sun, Zhanguo Li, Yudong Liu, Jing He
Publikováno v:
ImmunologyREFERENCES.
Given increased acceptance of the CoronaVac, there is an unmet need to assess the safety and immunogenic changes of CoronaVac in patients with rheumatic diseases (RD). Here we comprehensively analysed humoral and cellular responses in patient with RD